Adis R&D Insight

Visit: Wolters Kluwer Health | Wolters Kluwer | Contact Us

Adis R&D Insight

Adis R&D Insight is a database of drugs in development with a depth of content that is unequalled. The database has more than 23,000 in-depth profiles on drugs and research programs in development worldwide. These profiles are continuously monitored, and provide you with a comprehensive and powerful information resource for your market and competitor analysis. Each R&D Insight profile includes a detailed clinical and commercial overview of the products.

R&D Insight is part of the Business Intelligence product portfolio that consists of products to support customers along the drug development pipeline.

The Business Intelligence Portfolio of premier data solutions and services provides clients in the academic, corporate, government, and healthcare markets with decision support tools to:

Monitor over 23,000 profiles of drugs in development
Evaluate the strengths and weaknesses of products in development
Assess the commercial potential of upcoming products
Evaluate clinical study designs and strategies in a given therapeutic area
Identify in-licensing opportunities quickly

Other Products in the Business Intelligence Portfolio

Adis R&D Insight for Chemists - a datasource that combines the power of CambridgeSoft’s ChemDraw software with the drug development data in Adis R&D Insight

Adis Clinical Trials Insight - a key strategic research tool that provides rapid assessments of clinical trials as they are announced, presented and published.

Reactions Pharmacovigilance Service - a customized literature monitoring service that alerts drug marketing authorization holders to adverse events for specific drugs or drug classes.

PharmaNewsFeed - a customizable online service that delivers the latest market and product news directly to the desktop.

Custom Business Intelligence - a flexible portfolio of opportunities offering quality information in a variety of therapeutic areas.